Blood-based analysis of 84 microRNAs identifies molecules deregulated in individuals with type-2 diabetes, risk factors for the disease or metabolic syndrome
Micro-RNAs (miRNAs) are implicated in insulin-signaling and the development of type-2 diabetes (T2D). Their deregulated expression is mostly described in the pancreas, liver, skeletal muscle, or adipose tissue of diabetic animals. Relevant studies in humans are limited due to difficulties in accessi...
Saved in:
| Published in | Diabetes research and clinical practice Vol. 164; p. 108187 |
|---|---|
| Main Authors | , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Ireland
Elsevier B.V
01.06.2020
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Micro-RNAs (miRNAs) are implicated in insulin-signaling and the development of type-2 diabetes (T2D). Their deregulated expression is mostly described in the pancreas, liver, skeletal muscle, or adipose tissue of diabetic animals. Relevant studies in humans are limited due to difficulties in accessing tissue-biopsies. Though, circulating miRNAs are indicators of organ-specific pathophysiological events and could potentially serve as disease biomarkers. We explored the profile of 84 T2D-related miRNAs in peripheral blood of subjects with or without the disease. Methods: An RT-qPCR array screening 84 T2D-related miRNAs was applied in samples of T2D (n = 6) versus non-T2D (n = 6) subjects. The deregulated miRNAs were thereafter analyzed in peripheral blood samples of a validation cohort of 40 T2D and 37 non-T2D individuals [16 controls and 21 subjects with metabolic syndrome (Met-S) and/or T2D risk factors (T2D-RF)], using specific RT-qPCR assays. Correlations with clinicopathological parameters and risk factors were evaluated. Results: Subjects with the disease displayed decreased levels of miR-214-3p, miR-24-3p and let-7f-5p, compared to those without. MiRNA levels correlated with serum insulin and HbA1c levels in individuals with T2D or Met-S/T2D-RF, and with higher BMI, dyslipidemia and family history in controls. Conclusions: Blood levels of miR-214-3p, miR-24-3p and let-7f-5p are down-regulated in T2D- and Met-S/T2D-RF subjects. Future studies are needed to evaluate their potential as disease biomarkers and elucidate the associated tissue-specific pathogenetic mechanisms. |
|---|---|
| AbstractList | Micro-RNAs (miRNAs) are implicated in insulin-signaling and the development of type-2 diabetes (T2D). Their deregulated expression is mostly described in the pancreas, liver, skeletal muscle, or adipose tissue of diabetic animals. Relevant studies in humans are limited due to difficulties in accessing tissue-biopsies. Though, circulating miRNAs are indicators of organ-specific pathophysiological events and could potentially serve as disease biomarkers. We explored the profile of 84 T2D-related miRNAs in peripheral blood of subjects with or without the disease. Methods: An RT-qPCR array screening 84 T2D-related miRNAs was applied in samples of T2D (n = 6) versus non-T2D (n = 6) subjects. The deregulated miRNAs were thereafter analyzed in peripheral blood samples of a validation cohort of 40 T2D and 37 non-T2D individuals [16 controls and 21 subjects with metabolic syndrome (Met-S) and/or T2D risk factors (T2D-RF)], using specific RT-qPCR assays. Correlations with clinicopathological parameters and risk factors were evaluated. Results: Subjects with the disease displayed decreased levels of miR-214-3p, miR-24-3p and let-7f-5p, compared to those without. MiRNA levels correlated with serum insulin and HbA1c levels in individuals with T2D or Met-S/T2D-RF, and with higher BMI, dyslipidemia and family history in controls. Conclusions: Blood levels of miR-214-3p, miR-24-3p and let-7f-5p are down-regulated in T2D- and Met-S/T2D-RF subjects. Future studies are needed to evaluate their potential as disease biomarkers and elucidate the associated tissue-specific pathogenetic mechanisms. Micro-RNAs (miRNAs) are implicated in insulin-signaling and the development of type-2 diabetes (T2D). Their deregulated expression is mostly described in the pancreas, liver, skeletal muscle, or adipose tissue of diabetic animals. Relevant studies in humans are limited due to difficulties in accessing tissue-biopsies. Though, circulating miRNAs are indicators of organ-specific pathophysiological events and could potentially serve as disease biomarkers. We explored the profile of 84 T2D-related miRNAs in peripheral blood of subjects with or without the disease.AIMMicro-RNAs (miRNAs) are implicated in insulin-signaling and the development of type-2 diabetes (T2D). Their deregulated expression is mostly described in the pancreas, liver, skeletal muscle, or adipose tissue of diabetic animals. Relevant studies in humans are limited due to difficulties in accessing tissue-biopsies. Though, circulating miRNAs are indicators of organ-specific pathophysiological events and could potentially serve as disease biomarkers. We explored the profile of 84 T2D-related miRNAs in peripheral blood of subjects with or without the disease.An RT-qPCR array screening 84 T2D-related miRNAs was applied in samples of T2D (n = 6) versus non-T2D (n = 6) subjects. The deregulated miRNAs were thereafter analyzed in peripheral blood samples of a validation cohort of 40 T2D and 37 non-T2D individuals [16 controls and 21 subjects with metabolic syndrome (Met-S) and/or T2D risk factors (T2D-RF)], using specific RT-qPCR assays. Correlations with clinicopathological parameters and risk factors were evaluated.METHODSAn RT-qPCR array screening 84 T2D-related miRNAs was applied in samples of T2D (n = 6) versus non-T2D (n = 6) subjects. The deregulated miRNAs were thereafter analyzed in peripheral blood samples of a validation cohort of 40 T2D and 37 non-T2D individuals [16 controls and 21 subjects with metabolic syndrome (Met-S) and/or T2D risk factors (T2D-RF)], using specific RT-qPCR assays. Correlations with clinicopathological parameters and risk factors were evaluated.Subjects with the disease displayed decreased levels of miR-214-3p, miR-24-3p and let-7f-5p, compared to those without. MiRNA levels correlated with serum insulin and HbA1c levels in individuals with T2D or Met-S/T2D-RF, and with higher BMI, dyslipidemia and family history in controls.RESULTSSubjects with the disease displayed decreased levels of miR-214-3p, miR-24-3p and let-7f-5p, compared to those without. MiRNA levels correlated with serum insulin and HbA1c levels in individuals with T2D or Met-S/T2D-RF, and with higher BMI, dyslipidemia and family history in controls.Blood levels of miR-214-3p, miR-24-3p and let-7f-5p are down-regulated in T2D- and Met-S/T2D-RF subjects. Future studies are needed to evaluate their potential as disease biomarkers and elucidate the associated tissue-specific pathogenetic mechanisms.CONCLUSIONSBlood levels of miR-214-3p, miR-24-3p and let-7f-5p are down-regulated in T2D- and Met-S/T2D-RF subjects. Future studies are needed to evaluate their potential as disease biomarkers and elucidate the associated tissue-specific pathogenetic mechanisms. Micro-RNAs (miRNAs) are implicated in insulin-signaling and the development of type-2 diabetes (T2D). Their deregulated expression is mostly described in the pancreas, liver, skeletal muscle, or adipose tissue of diabetic animals. Relevant studies in humans are limited due to difficulties in accessing tissue-biopsies. Though, circulating miRNAs are indicators of organ-specific pathophysiological events and could potentially serve as disease biomarkers. We explored the profile of 84 T2D-related miRNAs in peripheral blood of subjects with or without the disease. An RT-qPCR array screening 84 T2D-related miRNAs was applied in samples of T2D (n = 6) versus non-T2D (n = 6) subjects. The deregulated miRNAs were thereafter analyzed in peripheral blood samples of a validation cohort of 40 T2D and 37 non-T2D individuals [16 controls and 21 subjects with metabolic syndrome (Met-S) and/or T2D risk factors (T2D-RF)], using specific RT-qPCR assays. Correlations with clinicopathological parameters and risk factors were evaluated. Subjects with the disease displayed decreased levels of miR-214-3p, miR-24-3p and let-7f-5p, compared to those without. MiRNA levels correlated with serum insulin and HbA1c levels in individuals with T2D or Met-S/T2D-RF, and with higher BMI, dyslipidemia and family history in controls. Blood levels of miR-214-3p, miR-24-3p and let-7f-5p are down-regulated in T2D- and Met-S/T2D-RF subjects. Future studies are needed to evaluate their potential as disease biomarkers and elucidate the associated tissue-specific pathogenetic mechanisms. |
| ArticleNumber | 108187 |
| Author | Scorilas, Andreas Fragoulis, Emmanuel G. Avgeris, Margaritis Mitrou, Panayota Maratou, Eirini Boutati, Eleni Christodoulou, Maria-Ioanna Kokkinopoulou, Ioanna |
| Author_xml | – sequence: 1 givenname: Margaritis surname: Avgeris fullname: Avgeris, Margaritis organization: Department of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece – sequence: 2 givenname: Ioanna surname: Kokkinopoulou fullname: Kokkinopoulou, Ioanna organization: Department of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece – sequence: 3 givenname: Eirini surname: Maratou fullname: Maratou, Eirini organization: Second Department of Internal Medicine, School of Medicine, Attikon Hospital, National and Kapodistrian University of Athens, Athens, Greece – sequence: 4 givenname: Panayota surname: Mitrou fullname: Mitrou, Panayota organization: Ministry of Health, Athens, Greece – sequence: 5 givenname: Eleni surname: Boutati fullname: Boutati, Eleni organization: Second Department of Internal Medicine, School of Medicine, Attikon Hospital, National and Kapodistrian University of Athens, Athens, Greece – sequence: 6 givenname: Andreas surname: Scorilas fullname: Scorilas, Andreas organization: Department of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece – sequence: 7 givenname: Emmanuel G. surname: Fragoulis fullname: Fragoulis, Emmanuel G. organization: Department of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece – sequence: 8 givenname: Maria-Ioanna surname: Christodoulou fullname: Christodoulou, Maria-Ioanna email: mchrist@biol.uoa.gr, Mar.Christodoulou@euc.ac.cy organization: Department of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32360711$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNUV1vFCEUnZga-6E_QcOjD84KDDPDxBhTG7-SRhOjz4SBi71bZtgCU7M_xv8q625f-lITAvfCOeeSc06roznMUFXPGV0xyrrX65VFPUZIK0757k4y2T-qTsrOa8l5f1SdFJz8Vx9XpymtKaVdI9on1XHDm472jJ1Uf977EGw96gSW6Fn7bcJEgiNSkAlNDN-_nieCFuaMDiGRKXgwiy-VhQi_Fq9zYeJclsVbtIv2ifzGfEXydgM1J7tvQob0ikRM18Rpk0NMxIVI8hWU5wRlOCntBFmPwaMhaTvbGCZ4Wj12RQ-eHc6z6ufHDz8uPteX3z59uTi_rI1gQ66ZleCYELoTbSesGEXHXO-6oae9EJTLVvJRS-CSGmAgOqfHoW0167tWa-6as-rlXncTw80CKasJkwHv9QxhSYo3g2TtwJqhQF8coMs4gVWbiJOOW3VnaQG82QOKeSlFcMpg1hnDnKNGrxhVuwDVWh0CVLsA1T7Awm7vse8GPMR7t-dBsekWIapkEGYDFiOYrGzABxXe3lMwHmc02l_D9j_4fwEgmc4F |
| CitedBy_id | crossref_primary_10_3390_ijms24021152 crossref_primary_10_1016_j_addr_2021_113918 crossref_primary_10_3390_ph15101269 crossref_primary_10_1096_fj_202001328R crossref_primary_10_2217_epi_2020_0247 crossref_primary_10_1177_25168657221130041 crossref_primary_10_3390_ijms24010616 crossref_primary_10_4239_wjd_v15_i6_1187 crossref_primary_10_1007_s12038_022_00295_2 crossref_primary_10_1016_j_bmcl_2021_128311 crossref_primary_10_1016_j_dsx_2021_102376 crossref_primary_10_1016_j_scitotenv_2023_167506 crossref_primary_10_2147_JIR_S369304 crossref_primary_10_3389_fnagi_2023_1114810 crossref_primary_10_3390_ijms22020550 crossref_primary_10_1016_j_numecd_2022_09_002 crossref_primary_10_3390_biology10060534 crossref_primary_10_3389_fendo_2021_774608 crossref_primary_10_3390_ijms22126337 |
| Cites_doi | 10.1530/EC-17-0248 10.1093/eurheartj/ehv599 10.1371/journal.pone.0055272 10.1007/s11033-013-2668-2 10.2337/db17-0141 10.1093/abbs/gmp035 10.1007/s40618-016-0473-1 10.3390/ijms18030456 10.3390/ijms17040564 10.3390/ijms19020522 10.1097/MPA.0b013e3181d12613 10.1016/j.gene.2018.03.056 10.1038/nrendo.2013.86 10.1038/nrm3313 10.1186/s12881-015-0219-5 10.2337/db11-1086 10.2337/db07-1614 10.1016/j.numecd.2019.03.002 10.2337/diaspect.27.4.276 10.1128/MCB.01433-10 10.3390/genes5030508 10.1097/01.hco.0000231412.15049.fb 10.1038/nature03076 10.1093/nar/gku1003 10.1038/ncb2211 10.1002/oby.22363 10.18632/oncotarget.18593 10.1016/j.tem.2007.10.001 10.1161/CIRCRESAHA.110.226357 10.1210/jc.2013-3843 10.1182/blood-2015-01-620278 10.1074/jbc.M117.812818 10.1093/jmcb/mjz004 10.1001/jama.2015.9536 10.1073/pnas.1118922109 10.1038/srep31506 10.2741/s483 10.1152/ajpendo.00236.2013 10.1038/nature10112 10.1152/ajpcell.00081.2017 10.1042/CS20130079 10.1006/meth.2001.1262 10.1001/jama.285.19.2486 10.3892/mmr.2014.2723 10.2337/db11-0171 10.2337/dc18-Sint01 10.1371/journal.pone.0188980 10.1074/jbc.M114.633990 |
| ContentType | Journal Article |
| Copyright | 2020 Elsevier B.V. Copyright © 2020 Elsevier B.V. All rights reserved. |
| Copyright_xml | – notice: 2020 Elsevier B.V. – notice: Copyright © 2020 Elsevier B.V. All rights reserved. |
| DBID | AAYXX CITATION NPM 7X8 |
| DOI | 10.1016/j.diabres.2020.108187 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1872-8227 |
| ExternalDocumentID | 32360711 10_1016_j_diabres_2020_108187 S016882272030437X |
| Genre | Journal Article |
| GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29F 4.4 457 4G. 53G 5GY 5RE 5VS 6PF 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQQT AAQXK AATTM AAWTL AAXKI AAXUO AAYWO ABBQC ABFNM ABGSF ABJNI ABMAC ABMZM ABUDA ABWVN ABXDB ACDAQ ACGFS ACIEU ACIUM ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADUVX ADVLN AEBSH AEHWI AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGRDE AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDZ HMK HMO HVGLF HZ~ IHE J1W KOM LZ1 M29 M41 MO0 N9A O-L O9- OAUVE OB0 ON- OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SEL SES SEW SPCBC SSH SSU SSZ T5K WUQ X7M Z5R ZGI ~G- AACTN AAIAV ABLVK ABYKQ AFKWA AHPSJ AJBFU AJOXV AMFUW DOVZS EFLBG LCYCR RIG ZA5 AAYXX AFCTW AGRNS CITATION NPM 7X8 |
| ID | FETCH-LOGICAL-c419t-1d8ef144a64564d4b461f7f6970744028582ba8e280ce1e46fab955a1765aa2f3 |
| IEDL.DBID | .~1 |
| ISSN | 0168-8227 1872-8227 |
| IngestDate | Thu Jul 10 22:58:39 EDT 2025 Thu Apr 03 07:02:15 EDT 2025 Tue Jul 01 01:02:47 EDT 2025 Thu Apr 24 23:01:18 EDT 2025 Fri Feb 23 02:48:06 EST 2024 Tue Aug 26 16:32:19 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Type-2 diabetes Insulin-pathway RT-qPCR array miRNAs Peripheral blood |
| Language | English |
| License | Copyright © 2020 Elsevier B.V. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c419t-1d8ef144a64564d4b461f7f6970744028582ba8e280ce1e46fab955a1765aa2f3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 32360711 |
| PQID | 2398159139 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2398159139 pubmed_primary_32360711 crossref_citationtrail_10_1016_j_diabres_2020_108187 crossref_primary_10_1016_j_diabres_2020_108187 elsevier_sciencedirect_doi_10_1016_j_diabres_2020_108187 elsevier_clinicalkey_doi_10_1016_j_diabres_2020_108187 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2020-06-01 |
| PublicationDateYYYYMMDD | 2020-06-01 |
| PublicationDate_xml | – month: 06 year: 2020 text: 2020-06-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Ireland |
| PublicationPlace_xml | – name: Ireland |
| PublicationTitle | Diabetes research and clinical practice |
| PublicationTitleAlternate | Diabetes Res Clin Pract |
| PublicationYear | 2020 |
| Publisher | Elsevier B.V |
| Publisher_xml | – name: Elsevier B.V |
| References | Bork-Jensen (b0085) 2014; 5 Cai (b0225) 2019 Honardoost, Keramati, Arefian, Mohammadi Yeganeh, Soleimani (b0170) 2018 Assmann, Recamonde-Mendoza, De Souza, Crispim (b0240) 2017; 6 Deng (b0210) 2017; 8 International Diabetes Federation (b0005) 2015 Expert Panel on Detection (b0120) 2001; 285 Jordan (b0050) 2011; 13 Wang (b0175) 2016; 6 He (b0100) 2017; 18 Rottiers, Naar (b0015) 2012; 13 Yang (b0230) 2018; 659 Introduction: Standards of Medical Care in Diabetes-2018. Diabetes Care 41, S1-S2, doi:10.2337/dc18-Sint01 (2018). Lopes (b0195) 2017; 9 Zeng (b0255) 2015; 11 Collins (b0260) 2014; 27 Poy (b0025) 2004; 432 Hamberg (b0140) 2016; 17 Gentile (b0250) 2019; 27 Desiderio (b0010) 2016; 39 McClelland, Kantharidis (b0110) 2014; 126 Huang (b0220) 2009; 41 Bera (b0180) 2017; 313 Zhao (b0070) 2010; 39 Li (b0160) 2015; 290 Goda, Murase, Kasezawa, Goda, Yamakawa-Kobayashi (b0060) 2015; 16 Szklarczyk (b0145) 2015; 43 Zhu (b0090) 2013; 40 Roggli (b0040) 2012; 61 Zhu (b0165) 2019; 43 Pullen, da Silva Xavier, Kelsey, Rutter (b0035) 2011; 31 van de Bunt (b0065) 2013; 8 Trajkovski (b0045) 2011; 474 Jiang (b0075) 2013; 305 Joglekar, Parekh, Hardikar (b0150) 2007; 18 Zhu (b0215) 2019 Santovito (b0245) 2014; 99 Nigro (b0185) 2018; 19 Massart (b0080) 2017; 66 Blumensatt (b0095) 1842; 275–283 Guay, Regazzi (b0105) 2013; 9 Frost, Olson (b0055) 2011; 108 El Ouaamari (b0030) 2008; 57 Fernandez-Valverde, Taft, Mattick (b0020) 2011; 60 Costantino, Paneni, Luscher, Cosentino (b0190) 2016; 37 de Candia (b0200) 2017; 12 Zampetaki (b0205) 2010; 107 Cui (b0155) 2018; 293 Livak, Schmittgen (b0135) 2001; 25 Nathan (b0125) 2015; 314 Xiang (b0235) 2015; 125 Cheng, Leiter (b0130) 2006; 21 El Ouaamari (10.1016/j.diabres.2020.108187_b0030) 2008; 57 Zhu (10.1016/j.diabres.2020.108187_b0165) 2019; 43 de Candia (10.1016/j.diabres.2020.108187_b0200) 2017; 12 Poy (10.1016/j.diabres.2020.108187_b0025) 2004; 432 Guay (10.1016/j.diabres.2020.108187_b0105) 2013; 9 Jiang (10.1016/j.diabres.2020.108187_b0075) 2013; 305 Expert Panel on Detection (10.1016/j.diabres.2020.108187_b0120) 2001; 285 Fernandez-Valverde (10.1016/j.diabres.2020.108187_b0020) 2011; 60 Zhu (10.1016/j.diabres.2020.108187_b0090) 2013; 40 Honardoost (10.1016/j.diabres.2020.108187_b0170) 2018 Xiang (10.1016/j.diabres.2020.108187_b0235) 2015; 125 Cui (10.1016/j.diabres.2020.108187_b0155) 2018; 293 Jordan (10.1016/j.diabres.2020.108187_b0050) 2011; 13 McClelland (10.1016/j.diabres.2020.108187_b0110) 2014; 126 Livak (10.1016/j.diabres.2020.108187_b0135) 2001; 25 International Diabetes Federation (10.1016/j.diabres.2020.108187_b0005) 2015 Huang (10.1016/j.diabres.2020.108187_b0220) 2009; 41 van de Bunt (10.1016/j.diabres.2020.108187_b0065) 2013; 8 Lopes (10.1016/j.diabres.2020.108187_b0195) 2017; 9 Yang (10.1016/j.diabres.2020.108187_b0230) 2018; 659 Frost (10.1016/j.diabres.2020.108187_b0055) 2011; 108 Pullen (10.1016/j.diabres.2020.108187_b0035) 2011; 31 Zampetaki (10.1016/j.diabres.2020.108187_b0205) 2010; 107 Zeng (10.1016/j.diabres.2020.108187_b0255) 2015; 11 Bera (10.1016/j.diabres.2020.108187_b0180) 2017; 313 Collins (10.1016/j.diabres.2020.108187_b0260) 2014; 27 Desiderio (10.1016/j.diabres.2020.108187_b0010) 2016; 39 Assmann (10.1016/j.diabres.2020.108187_b0240) 2017; 6 Nathan (10.1016/j.diabres.2020.108187_b0125) 2015; 314 Szklarczyk (10.1016/j.diabres.2020.108187_b0145) 2015; 43 Massart (10.1016/j.diabres.2020.108187_b0080) 2017; 66 Zhao (10.1016/j.diabres.2020.108187_b0070) 2010; 39 Nigro (10.1016/j.diabres.2020.108187_b0185) 2018; 19 Roggli (10.1016/j.diabres.2020.108187_b0040) 2012; 61 Joglekar (10.1016/j.diabres.2020.108187_b0150) 2007; 18 Wang (10.1016/j.diabres.2020.108187_b0175) 2016; 6 Costantino (10.1016/j.diabres.2020.108187_b0190) 2016; 37 Zhu (10.1016/j.diabres.2020.108187_b0215) 2019 Hamberg (10.1016/j.diabres.2020.108187_b0140) 2016; 17 Rottiers (10.1016/j.diabres.2020.108187_b0015) 2012; 13 Bork-Jensen (10.1016/j.diabres.2020.108187_b0085) 2014; 5 Trajkovski (10.1016/j.diabres.2020.108187_b0045) 2011; 474 Blumensatt (10.1016/j.diabres.2020.108187_b0095) 1842; 275–283 Goda (10.1016/j.diabres.2020.108187_b0060) 2015; 16 10.1016/j.diabres.2020.108187_b0115 Deng (10.1016/j.diabres.2020.108187_b0210) 2017; 8 Cai (10.1016/j.diabres.2020.108187_b0225) 2019 Gentile (10.1016/j.diabres.2020.108187_b0250) 2019; 27 Cheng (10.1016/j.diabres.2020.108187_b0130) 2006; 21 He (10.1016/j.diabres.2020.108187_b0100) 2017; 18 Santovito (10.1016/j.diabres.2020.108187_b0245) 2014; 99 Li (10.1016/j.diabres.2020.108187_b0160) 2015; 290 |
| References_xml | – volume: 8 year: 2013 ident: b0065 article-title: The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis publication-title: PLoS ONE – volume: 18 year: 2017 ident: b0100 article-title: A Systematic Study of Dysregulated MicroRNA in Type 2 Diabetes Mellitus publication-title: Int J Mol Sci – volume: 43 start-page: D447 year: 2015 end-page: 452 ident: b0145 article-title: STRING v10: protein-protein interaction networks, integrated over the tree of life publication-title: Nucleic Acids Res – volume: 39 start-page: 843 year: 2010 end-page: 846 ident: b0070 article-title: Up-regulated pancreatic tissue microRNA-375 associates with human type 2 diabetes through beta-cell deficit and islet amyloid deposition publication-title: Pancreas – volume: 314 start-page: 1052 year: 2015 end-page: 1062 ident: b0125 article-title: Diabetes: Advances in Diagnosis and Treatment publication-title: JAMA – volume: 25 start-page: 402 year: 2001 end-page: 408 ident: b0135 article-title: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method publication-title: Methods – volume: 12 year: 2017 ident: b0200 article-title: A unique plasma microRNA profile defines type 2 diabetes progression publication-title: PLoS ONE – volume: 31 start-page: 3182 year: 2011 end-page: 3194 ident: b0035 article-title: miR-29a and miR-29b contribute to pancreatic beta-cell-specific silencing of monocarboxylate transporter 1 (Mct1) publication-title: Mol Cell Biol – volume: 43 start-page: 345 year: 2019 end-page: 357 ident: b0165 article-title: lncRNA MEG3 promotes hepatic insulin resistance by serving as a competing endogenous RNA of miR-214 to regulate ATF4 expression publication-title: Int J Mol Med – volume: 61 start-page: 1742 year: 2012 end-page: 1751 ident: b0040 article-title: Changes in microRNA expression contribute to pancreatic beta-cell dysfunction in prediabetic NOD mice publication-title: Diabetes – volume: 11 start-page: 67 year: 2015 end-page: 74 ident: b0255 article-title: Systematic profiling of mRNA and miRNA expression in the pancreatic islets of spontaneously diabetic Goto-Kakizaki rats publication-title: Mol Med Rep – year: 2019 ident: b0215 article-title: MicroRNA-24 promotes pancreatic beta cells toward dedifferentiation to avoid endoplasmic reticulum stress-induced apoptosis publication-title: J Mol Cell Biol – volume: 60 start-page: 1825 year: 2011 end-page: 1831 ident: b0020 article-title: MicroRNAs in beta-cell biology, insulin resistance, diabetes and its complications publication-title: Diabetes – volume: 40 start-page: 5669 year: 2013 end-page: 5675 ident: b0090 article-title: FFAs and adipokine-mediated regulation of hsa-miR-143 expression in human adipocytes publication-title: Mol Biol Rep – volume: 290 start-page: 8185 year: 2015 end-page: 8195 ident: b0160 article-title: MicroRNA-214 suppresses gluconeogenesis by targeting activating transcriptional factor 4 publication-title: J Biol Chem – volume: 126 start-page: 95 year: 2014 end-page: 110 ident: b0110 article-title: microRNA in the development of diabetic complications publication-title: Clin Sci (Lond) – volume: 285 start-page: 2486 year: 2001 end-page: 2497 ident: b0120 article-title: Evaluation and Treatment of High Blood Cholesterol in Adults Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) publication-title: JAMA – volume: 108 start-page: 21075 year: 2011 end-page: 21080 ident: b0055 article-title: Control of glucose homeostasis and insulin sensitivity by the Let-7 family of microRNAs publication-title: Proc Natl Acad Sci U S A – volume: 275–283 start-page: 2014 year: 1842 ident: b0095 article-title: Adipocyte-derived factors impair insulin signaling in differentiated human vascular smooth muscle cells via the upregulation of miR-143 publication-title: Biochim Biophys Acta – volume: 57 start-page: 2708 year: 2008 end-page: 2717 ident: b0030 article-title: miR-375 targets 3'-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells publication-title: Diabetes – volume: 39 start-page: 1095 year: 2016 end-page: 1103 ident: b0010 article-title: Epigenetics: spotlight on type 2 diabetes and obesity publication-title: J Endocrinol Invest – volume: 27 start-page: 276 year: 2014 end-page: 280 ident: b0260 article-title: The diabetes-cancer link publication-title: Diabetes Spectr – year: 2018 ident: b0170 article-title: Network of three specific microRNAs influence type 2 diabetes through inducing insulin resistance in muscle cell lines publication-title: J Cell Biochem – volume: 27 start-page: 245 year: 2019 end-page: 254 ident: b0250 article-title: miR-20b, miR-296, and Let-7f Expression in Human Adipose Tissue is Related to Obesity and Type 2 Diabetes publication-title: Obesity (Silver Spring) – volume: 21 start-page: 400 year: 2006 end-page: 404 ident: b0130 article-title: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines publication-title: Curr Opin Cardiol – volume: 99 start-page: E1681 year: 2014 end-page: 1685 ident: b0245 article-title: Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic control publication-title: J Clin Endocrinol Metab – volume: 5 start-page: 508 year: 2014 end-page: 517 ident: b0085 article-title: Genetic versus Non-Genetic Regulation of miR-103, miR-143 and miR-483-3p Expression in Adipose Tissue and Their Metabolic Implications-A Twin Study publication-title: Genes (Basel) – volume: 6 start-page: 31506 year: 2016 ident: b0175 article-title: Cross talk between miR-214 and PTEN attenuates glomerular hypertrophy under diabetic conditions publication-title: Sci Rep – volume: 659 start-page: 67 year: 2018 end-page: 76 ident: b0230 article-title: MicroRNA-24 regulates vascular remodeling via inhibiting PDGF-BB pathway in diabetic rat model publication-title: Gene – volume: 6 start-page: 773 year: 2017 end-page: 790 ident: b0240 article-title: MicroRNA expression profiles and type 1 diabetes mellitus: systematic review and bioinformatic analysis publication-title: Endocr Connect – volume: 66 start-page: 1807 year: 2017 end-page: 1818 ident: b0080 article-title: Altered miR-29 Expression in Type 2 Diabetes Influences Glucose and Lipid Metabolism in Skeletal Muscle publication-title: Diabetes – volume: 13 start-page: 434 year: 2011 end-page: 446 ident: b0050 article-title: Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism publication-title: Nat Cell Biol – volume: 8 start-page: 63038 year: 2017 end-page: 63046 ident: b0210 article-title: Circulating miRNA-24 and its target YKL-40 as potential biomarkers in patients with coronary heart disease and type 2 diabetes mellitus publication-title: Oncotarget – volume: 19 year: 2018 ident: b0185 article-title: miR-214-Dependent Increase of PHLPP2 Levels Mediates the Impairment of Insulin-Stimulated Akt Activation in Mouse Aortic Endothelial Cells Exposed to Methylglyoxal publication-title: Int J Mol Sci – volume: 41 start-page: 472 year: 2009 end-page: 477 ident: b0220 article-title: MicroRNA expression profiling in diabetic GK rat model publication-title: Acta Biochim Biophys Sin (Shanghai) – volume: 9 start-page: 513 year: 2013 end-page: 521 ident: b0105 article-title: Circulating microRNAs as novel biomarkers for diabetes mellitus publication-title: Nat Rev Endocrinol – volume: 16 start-page: 75 year: 2015 ident: b0060 article-title: Polymorphism in microRNA-binding site in HNF1B influences the susceptibility of type 2 diabetes mellitus: a population based case-control study publication-title: BMC Med Genet – year: 2019 ident: b0225 article-title: MicroRNA-24 attenuates vascular remodeling in diabetic rats through PI3K/Akt signaling pathway publication-title: Nutr Metab Cardiovasc Dis – volume: 313 start-page: C430 year: 2017 end-page: C447 ident: b0180 article-title: Reciprocal regulation of miR-214 and PTEN by high glucose regulates renal glomerular mesangial and proximal tubular epithelial cell hypertrophy and matrix expansion publication-title: Am J Physiol Cell Physiol – volume: 107 start-page: 810 year: 2010 end-page: 817 ident: b0205 article-title: Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes publication-title: Circ Res – volume: 17 start-page: 564 year: 2016 ident: b0140 article-title: MiRTargetLink–miRNAs, Genes and Interaction Networks publication-title: Int J Mol Sci – volume: 305 start-page: E1359 year: 2013 end-page: 1366 ident: b0075 article-title: Autocrine role of interleukin-13 on skeletal muscle glucose metabolism in type 2 diabetic patients involves microRNA let-7 publication-title: Am J Physiol Endocrinol Metab – volume: 9 start-page: 194 year: 2017 end-page: 229 ident: b0195 article-title: mRNA-miRNA integrative analysis of diabetes-induced cardiomyopathy in rats publication-title: Front Biosci (Schol Ed) – volume: 432 start-page: 226 year: 2004 end-page: 230 ident: b0025 article-title: A pancreatic islet-specific microRNA regulates insulin secretion publication-title: Nature – year: 2015 ident: b0005 article-title: IDF Diabetes Atlas – volume: 293 start-page: 4097 year: 2018 end-page: 4109 ident: b0155 article-title: The long non-coding RNA Gm10768 activates hepatic gluconeogenesis by sequestering microRNA-214 in mice publication-title: J Biol Chem – volume: 18 start-page: 393 year: 2007 end-page: 400 ident: b0150 article-title: New pancreas from old: microregulators of pancreas regeneration publication-title: Trends Endocrinol Metab – volume: 37 start-page: 572 year: 2016 end-page: 576 ident: b0190 article-title: MicroRNA profiling unveils hyperglycaemic memory in the diabetic heart publication-title: Eur Heart J – volume: 13 start-page: 239 year: 2012 end-page: 250 ident: b0015 article-title: MicroRNAs in metabolism and metabolic disorders publication-title: Nat Rev Mol Cell Biol – volume: 474 start-page: 649 year: 2011 end-page: 653 ident: b0045 article-title: MicroRNAs 103 and 107 regulate insulin sensitivity publication-title: Nature – reference: Introduction: Standards of Medical Care in Diabetes-2018. Diabetes Care 41, S1-S2, doi:10.2337/dc18-Sint01 (2018). – volume: 125 start-page: 3377 year: 2015 end-page: 3387 ident: b0235 article-title: Hyperglycemia repression of miR-24 coordinately upregulates endothelial cell expression and secretion of von Willebrand factor publication-title: Blood – volume: 6 start-page: 773 year: 2017 ident: 10.1016/j.diabres.2020.108187_b0240 article-title: MicroRNA expression profiles and type 1 diabetes mellitus: systematic review and bioinformatic analysis publication-title: Endocr Connect doi: 10.1530/EC-17-0248 – volume: 37 start-page: 572 year: 2016 ident: 10.1016/j.diabres.2020.108187_b0190 article-title: MicroRNA profiling unveils hyperglycaemic memory in the diabetic heart publication-title: Eur Heart J doi: 10.1093/eurheartj/ehv599 – volume: 8 year: 2013 ident: 10.1016/j.diabres.2020.108187_b0065 article-title: The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis publication-title: PLoS ONE doi: 10.1371/journal.pone.0055272 – volume: 40 start-page: 5669 year: 2013 ident: 10.1016/j.diabres.2020.108187_b0090 article-title: FFAs and adipokine-mediated regulation of hsa-miR-143 expression in human adipocytes publication-title: Mol Biol Rep doi: 10.1007/s11033-013-2668-2 – volume: 66 start-page: 1807 year: 2017 ident: 10.1016/j.diabres.2020.108187_b0080 article-title: Altered miR-29 Expression in Type 2 Diabetes Influences Glucose and Lipid Metabolism in Skeletal Muscle publication-title: Diabetes doi: 10.2337/db17-0141 – volume: 41 start-page: 472 year: 2009 ident: 10.1016/j.diabres.2020.108187_b0220 article-title: MicroRNA expression profiling in diabetic GK rat model publication-title: Acta Biochim Biophys Sin (Shanghai) doi: 10.1093/abbs/gmp035 – volume: 39 start-page: 1095 year: 2016 ident: 10.1016/j.diabres.2020.108187_b0010 article-title: Epigenetics: spotlight on type 2 diabetes and obesity publication-title: J Endocrinol Invest doi: 10.1007/s40618-016-0473-1 – year: 2015 ident: 10.1016/j.diabres.2020.108187_b0005 – volume: 18 year: 2017 ident: 10.1016/j.diabres.2020.108187_b0100 article-title: A Systematic Study of Dysregulated MicroRNA in Type 2 Diabetes Mellitus publication-title: Int J Mol Sci doi: 10.3390/ijms18030456 – volume: 17 start-page: 564 year: 2016 ident: 10.1016/j.diabres.2020.108187_b0140 article-title: MiRTargetLink–miRNAs, Genes and Interaction Networks publication-title: Int J Mol Sci doi: 10.3390/ijms17040564 – volume: 19 year: 2018 ident: 10.1016/j.diabres.2020.108187_b0185 article-title: miR-214-Dependent Increase of PHLPP2 Levels Mediates the Impairment of Insulin-Stimulated Akt Activation in Mouse Aortic Endothelial Cells Exposed to Methylglyoxal publication-title: Int J Mol Sci doi: 10.3390/ijms19020522 – volume: 39 start-page: 843 year: 2010 ident: 10.1016/j.diabres.2020.108187_b0070 article-title: Up-regulated pancreatic tissue microRNA-375 associates with human type 2 diabetes through beta-cell deficit and islet amyloid deposition publication-title: Pancreas doi: 10.1097/MPA.0b013e3181d12613 – volume: 659 start-page: 67 year: 2018 ident: 10.1016/j.diabres.2020.108187_b0230 article-title: MicroRNA-24 regulates vascular remodeling via inhibiting PDGF-BB pathway in diabetic rat model publication-title: Gene doi: 10.1016/j.gene.2018.03.056 – volume: 9 start-page: 513 year: 2013 ident: 10.1016/j.diabres.2020.108187_b0105 article-title: Circulating microRNAs as novel biomarkers for diabetes mellitus publication-title: Nat Rev Endocrinol doi: 10.1038/nrendo.2013.86 – volume: 13 start-page: 239 year: 2012 ident: 10.1016/j.diabres.2020.108187_b0015 article-title: MicroRNAs in metabolism and metabolic disorders publication-title: Nat Rev Mol Cell Biol doi: 10.1038/nrm3313 – volume: 16 start-page: 75 year: 2015 ident: 10.1016/j.diabres.2020.108187_b0060 article-title: Polymorphism in microRNA-binding site in HNF1B influences the susceptibility of type 2 diabetes mellitus: a population based case-control study publication-title: BMC Med Genet doi: 10.1186/s12881-015-0219-5 – volume: 61 start-page: 1742 year: 2012 ident: 10.1016/j.diabres.2020.108187_b0040 article-title: Changes in microRNA expression contribute to pancreatic beta-cell dysfunction in prediabetic NOD mice publication-title: Diabetes doi: 10.2337/db11-1086 – year: 2018 ident: 10.1016/j.diabres.2020.108187_b0170 article-title: Network of three specific microRNAs influence type 2 diabetes through inducing insulin resistance in muscle cell lines publication-title: J Cell Biochem – volume: 57 start-page: 2708 year: 2008 ident: 10.1016/j.diabres.2020.108187_b0030 article-title: miR-375 targets 3'-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells publication-title: Diabetes doi: 10.2337/db07-1614 – year: 2019 ident: 10.1016/j.diabres.2020.108187_b0225 article-title: MicroRNA-24 attenuates vascular remodeling in diabetic rats through PI3K/Akt signaling pathway publication-title: Nutr Metab Cardiovasc Dis doi: 10.1016/j.numecd.2019.03.002 – volume: 27 start-page: 276 year: 2014 ident: 10.1016/j.diabres.2020.108187_b0260 article-title: The diabetes-cancer link publication-title: Diabetes Spectr doi: 10.2337/diaspect.27.4.276 – volume: 31 start-page: 3182 year: 2011 ident: 10.1016/j.diabres.2020.108187_b0035 article-title: miR-29a and miR-29b contribute to pancreatic beta-cell-specific silencing of monocarboxylate transporter 1 (Mct1) publication-title: Mol Cell Biol doi: 10.1128/MCB.01433-10 – volume: 5 start-page: 508 year: 2014 ident: 10.1016/j.diabres.2020.108187_b0085 article-title: Genetic versus Non-Genetic Regulation of miR-103, miR-143 and miR-483-3p Expression in Adipose Tissue and Their Metabolic Implications-A Twin Study publication-title: Genes (Basel) doi: 10.3390/genes5030508 – volume: 21 start-page: 400 year: 2006 ident: 10.1016/j.diabres.2020.108187_b0130 article-title: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines publication-title: Curr Opin Cardiol doi: 10.1097/01.hco.0000231412.15049.fb – volume: 432 start-page: 226 year: 2004 ident: 10.1016/j.diabres.2020.108187_b0025 article-title: A pancreatic islet-specific microRNA regulates insulin secretion publication-title: Nature doi: 10.1038/nature03076 – volume: 43 start-page: D447 year: 2015 ident: 10.1016/j.diabres.2020.108187_b0145 article-title: STRING v10: protein-protein interaction networks, integrated over the tree of life publication-title: Nucleic Acids Res doi: 10.1093/nar/gku1003 – volume: 13 start-page: 434 year: 2011 ident: 10.1016/j.diabres.2020.108187_b0050 article-title: Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism publication-title: Nat Cell Biol doi: 10.1038/ncb2211 – volume: 43 start-page: 345 year: 2019 ident: 10.1016/j.diabres.2020.108187_b0165 article-title: lncRNA MEG3 promotes hepatic insulin resistance by serving as a competing endogenous RNA of miR-214 to regulate ATF4 expression publication-title: Int J Mol Med – volume: 27 start-page: 245 year: 2019 ident: 10.1016/j.diabres.2020.108187_b0250 article-title: miR-20b, miR-296, and Let-7f Expression in Human Adipose Tissue is Related to Obesity and Type 2 Diabetes publication-title: Obesity (Silver Spring) doi: 10.1002/oby.22363 – volume: 8 start-page: 63038 year: 2017 ident: 10.1016/j.diabres.2020.108187_b0210 article-title: Circulating miRNA-24 and its target YKL-40 as potential biomarkers in patients with coronary heart disease and type 2 diabetes mellitus publication-title: Oncotarget doi: 10.18632/oncotarget.18593 – volume: 18 start-page: 393 year: 2007 ident: 10.1016/j.diabres.2020.108187_b0150 article-title: New pancreas from old: microregulators of pancreas regeneration publication-title: Trends Endocrinol Metab doi: 10.1016/j.tem.2007.10.001 – volume: 107 start-page: 810 year: 2010 ident: 10.1016/j.diabres.2020.108187_b0205 article-title: Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes publication-title: Circ Res doi: 10.1161/CIRCRESAHA.110.226357 – volume: 99 start-page: E1681 year: 2014 ident: 10.1016/j.diabres.2020.108187_b0245 article-title: Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic control publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2013-3843 – volume: 125 start-page: 3377 year: 2015 ident: 10.1016/j.diabres.2020.108187_b0235 article-title: Hyperglycemia repression of miR-24 coordinately upregulates endothelial cell expression and secretion of von Willebrand factor publication-title: Blood doi: 10.1182/blood-2015-01-620278 – volume: 293 start-page: 4097 year: 2018 ident: 10.1016/j.diabres.2020.108187_b0155 article-title: The long non-coding RNA Gm10768 activates hepatic gluconeogenesis by sequestering microRNA-214 in mice publication-title: J Biol Chem doi: 10.1074/jbc.M117.812818 – year: 2019 ident: 10.1016/j.diabres.2020.108187_b0215 article-title: MicroRNA-24 promotes pancreatic beta cells toward dedifferentiation to avoid endoplasmic reticulum stress-induced apoptosis publication-title: J Mol Cell Biol doi: 10.1093/jmcb/mjz004 – volume: 314 start-page: 1052 year: 2015 ident: 10.1016/j.diabres.2020.108187_b0125 article-title: Diabetes: Advances in Diagnosis and Treatment publication-title: JAMA doi: 10.1001/jama.2015.9536 – volume: 108 start-page: 21075 year: 2011 ident: 10.1016/j.diabres.2020.108187_b0055 article-title: Control of glucose homeostasis and insulin sensitivity by the Let-7 family of microRNAs publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1118922109 – volume: 275–283 start-page: 2014 year: 1842 ident: 10.1016/j.diabres.2020.108187_b0095 article-title: Adipocyte-derived factors impair insulin signaling in differentiated human vascular smooth muscle cells via the upregulation of miR-143 publication-title: Biochim Biophys Acta – volume: 6 start-page: 31506 year: 2016 ident: 10.1016/j.diabres.2020.108187_b0175 article-title: Cross talk between miR-214 and PTEN attenuates glomerular hypertrophy under diabetic conditions publication-title: Sci Rep doi: 10.1038/srep31506 – volume: 9 start-page: 194 year: 2017 ident: 10.1016/j.diabres.2020.108187_b0195 article-title: mRNA-miRNA integrative analysis of diabetes-induced cardiomyopathy in rats publication-title: Front Biosci (Schol Ed) doi: 10.2741/s483 – volume: 305 start-page: E1359 year: 2013 ident: 10.1016/j.diabres.2020.108187_b0075 article-title: Autocrine role of interleukin-13 on skeletal muscle glucose metabolism in type 2 diabetic patients involves microRNA let-7 publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00236.2013 – volume: 474 start-page: 649 year: 2011 ident: 10.1016/j.diabres.2020.108187_b0045 article-title: MicroRNAs 103 and 107 regulate insulin sensitivity publication-title: Nature doi: 10.1038/nature10112 – volume: 313 start-page: C430 year: 2017 ident: 10.1016/j.diabres.2020.108187_b0180 article-title: Reciprocal regulation of miR-214 and PTEN by high glucose regulates renal glomerular mesangial and proximal tubular epithelial cell hypertrophy and matrix expansion publication-title: Am J Physiol Cell Physiol doi: 10.1152/ajpcell.00081.2017 – volume: 126 start-page: 95 year: 2014 ident: 10.1016/j.diabres.2020.108187_b0110 article-title: microRNA in the development of diabetic complications publication-title: Clin Sci (Lond) doi: 10.1042/CS20130079 – volume: 25 start-page: 402 year: 2001 ident: 10.1016/j.diabres.2020.108187_b0135 article-title: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method publication-title: Methods doi: 10.1006/meth.2001.1262 – volume: 285 start-page: 2486 year: 2001 ident: 10.1016/j.diabres.2020.108187_b0120 publication-title: JAMA doi: 10.1001/jama.285.19.2486 – volume: 11 start-page: 67 year: 2015 ident: 10.1016/j.diabres.2020.108187_b0255 article-title: Systematic profiling of mRNA and miRNA expression in the pancreatic islets of spontaneously diabetic Goto-Kakizaki rats publication-title: Mol Med Rep doi: 10.3892/mmr.2014.2723 – volume: 60 start-page: 1825 year: 2011 ident: 10.1016/j.diabres.2020.108187_b0020 article-title: MicroRNAs in beta-cell biology, insulin resistance, diabetes and its complications publication-title: Diabetes doi: 10.2337/db11-0171 – ident: 10.1016/j.diabres.2020.108187_b0115 doi: 10.2337/dc18-Sint01 – volume: 12 year: 2017 ident: 10.1016/j.diabres.2020.108187_b0200 article-title: A unique plasma microRNA profile defines type 2 diabetes progression publication-title: PLoS ONE doi: 10.1371/journal.pone.0188980 – volume: 290 start-page: 8185 year: 2015 ident: 10.1016/j.diabres.2020.108187_b0160 article-title: MicroRNA-214 suppresses gluconeogenesis by targeting activating transcriptional factor 4 publication-title: J Biol Chem doi: 10.1074/jbc.M114.633990 |
| SSID | ssj0006345 |
| Score | 2.3992436 |
| Snippet | Micro-RNAs (miRNAs) are implicated in insulin-signaling and the development of type-2 diabetes (T2D). Their deregulated expression is mostly described in the... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 108187 |
| SubjectTerms | Insulin-pathway miRNAs Peripheral blood RT-qPCR array Type-2 diabetes |
| Title | Blood-based analysis of 84 microRNAs identifies molecules deregulated in individuals with type-2 diabetes, risk factors for the disease or metabolic syndrome |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S016882272030437X https://dx.doi.org/10.1016/j.diabres.2020.108187 https://www.ncbi.nlm.nih.gov/pubmed/32360711 https://www.proquest.com/docview/2398159139 |
| Volume | 164 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqIiEuiDfLoxokjmS3fsY5LhXVAuoegEp7i-zEllJ1sxW7vfJP-K_MxM5WSKAibknkURJ7bH-e-WaGsbdWeq4bh8gt4GxCpbCF1zwWzoeggtCxacmje7Y0i3P1aaVXB-xkjIUhWmVe-9OaPqzW-cks9-bsqutmXxGsIDwc_IiUoGdFEeyqJC2f_riheRipEo3R2IJa30TxzC6mZN_EUy0eE8XAtuPErPvz_vQ3_DnsQ6cP2P0MIGGevvEhOwj9I3b3LLvIH7Of7wcqOu1OLbiccgQ2EayCNbHvviznW-jaxBIKW1inArl4RXU7h8r0KNn10O1jtbZA5logc20hYDTXvgPipUOu2AOIfgHRJGSXD-DtOuxQxy67BsbECE_Y-emHbyeLItdgKBrFq13BWxsiHrqcobwzrfLK8FhGU5XHlFpQWG2FdzYIe9wEHpSJzldaO14a7ZyI8ik77Dd9eM7AyVJG44JsEReUVlmvnfCmEo2xrdRuwtTY83WTE5RTnYzLemSiXdR5wGoasDoN2IRN92JXKUPHbQJmHNZ6DD_FBbPGPeQ2QbsX_E1H_0X0zag_Nc5fcsq4PmyusZGsLEJKBOIT9iwp1v43pJCU_o-_-P8Xv2T36C6R216xw9336_AaYdTOHw3z5IjdmX_8vFj-AllGHYg |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6VVAIuFW_S8hgkjrjpPr0-phVVSpscoJVys9b2WnLVOBVJfw7_lRnv2ggJVMTNdjJysjs7--3Ot98w9tHKguvSIXLzOJrQKWxSaF4nrvBeeaHrsqKM7nxhZlfqy1Ivd9hJfxaGaJUx9oeY3kXr-GQSW3Ny2zSTbwhWEB52eUQS6Fk-YLukTqVHbHd6dj5bDAHZSBWYjMYmZPDrIM_k-pC2OHFhiytF0RHuOJHr_jxF_Q2CdlPR6RO2FzEkTMPPfMp2fPuMPZzHLPlz9uO4Y6PTBFWBi6ojsK7BKlgRAe_rYrqBpgpEIb-BVaiRi1dUurMrTo-WTQvNcFxrA7RjC7Rjmwjod2w_AVHTIRbtAQTAgIASYtYH8Hblt-hmN00JvTbCC3Z1-vnyZJbEMgxJqXi2TXhlfY3rLmdIeqZShTK8TmuTpUekLiistqJw1gt7VHrulaldkWnteGq0c6KWL9moXbf-NQMnU1kb52WF0CC1yhbaicJkojS2ktqNmepbPi-jRjmVyrjJezLadR47LKcOy0OHjdnhYHYbRDruMzB9t-b9CVSMmTlOI_cZ2sHwNzf9F9MPvf_kOIQpL-Nav77DL8nMIqpELD5mr4JjDX9DCkkKgHz__1_8nj2aXc4v8ouzxfkBe0yfBK7bGzbafr_zbxFVbYt3cdT8BA5JIDk |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Blood-based+analysis+of+84+microRNAs+identifies+molecules+deregulated+in+individuals+with+type-2+diabetes%2C+risk+factors+for+the+disease+or+metabolic+syndrome&rft.jtitle=Diabetes+research+and+clinical+practice&rft.au=Avgeris%2C+Margaritis&rft.au=Kokkinopoulou%2C+Ioanna&rft.au=Maratou%2C+Eirini&rft.au=Mitrou%2C+Panayota&rft.date=2020-06-01&rft.pub=Elsevier+B.V&rft.issn=0168-8227&rft.eissn=1872-8227&rft.volume=164&rft_id=info:doi/10.1016%2Fj.diabres.2020.108187&rft.externalDocID=S016882272030437X |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0168-8227&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0168-8227&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0168-8227&client=summon |